Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04046497 · ClinicalTrials.gov registry record · Phase 4

Artificial Intelligence to Measure Adherence to Oral Medication

A Phase 4 study of First Episode Psychosis, sponsored by Northwell Health.

Recruiting
Registry status
Phase 4
Development phase
200
Enrollment target
5
Study locations

NCT04046497 is a Phase 4 study of First Episode Psychosis that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 200 participants, below the 6,408-participant average among 8 other First Episode Psychosis trials with a reported enrollment target (97% lower). The trial reports 5 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04046497, a Phase 4 study of First Episode Psychosis, is actively recruiting participants, sponsored by Northwell Health.

RECRUITING
Registry status
Phase 4
Development phase
200 participants
Enrollment target
5
Study locations

Study Summary

The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis.

Conditions Studied

First Episode Psychosis

Interventions

  • OTHER Usual Care
  • OTHER Smartphone App

Study Locations (5)

Michigan

  • InterAct - Grand Rapids
  • InterAct of Michigan - Kalamazoo

Oklahoma

  • Red Rock - Oklahoma City
  • Family and Children's Services - Tulsa

Florida

  • Citrus Health - Hialeah

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2020-11-20
Est. Completion 2024-12-31
Phase Phase 4

Sponsor

Northwell Health

370 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04046497

The ClinicalTrials.gov registry entry for NCT04046497 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,408-participant average among 8 other First Episode Psychosis trials with a reported enrollment target (97% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with First Episode Psychosis appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT04046497 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Michigan, Oklahoma, Florida.

Frequently Asked Questions

What is clinical trial NCT04046497 about?

NCT04046497 is a clinical study titled "Artificial Intelligence to Measure Adherence to Oral Medication". The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis.

What is the current status of trial NCT04046497?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2020-11-20. Estimated completion is 2024-12-31.

What conditions does trial NCT04046497 study?

This clinical trial studies the following conditions: First Episode Psychosis.

What interventions are being tested in trial NCT04046497?

The interventions under investigation include: Usual Care (OTHER), Smartphone App (OTHER).

Who is sponsoring clinical trial NCT04046497?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04046497 being conducted?

This trial has 5 study locations across Florida, Michigan, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for First Episode Psychosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

First Episode Psychosis

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.